PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112562
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112562
Esoteric Testing Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2026 - 2032)
The global esoteric testing market was valued at USD 30.1 billion in 2025 and is projected to reach USD 72.5 billion by 2032, growing at a CAGR of 13.4% between 2026 and 2032. Growth is being driven by the rising prevalence of chronic, infectious, and genetic diseases, as non-communicable diseases account for approximately 74% of global deaths annually, according to the World Health Organization.
Genomic sequencing costs have collapsed, making advanced diagnostics commercially viable. The cost of sequencing a human genome has fallen from approximately USD 95 million in 2001 to around USD 500 in recent years, according to the National Human Genome Research Institute.
Cancer incidence keeps rising, pushing demand toward molecular confirmation before treatment. There were approximately 20 million new cancer cases globally in 2022, projected to reach 35 million by 2050, according to the International Agency for Research on Cancer.
Key Insights
Oncology Testing is the largest test type at 35% share, requiring molecular confirmation before targeted therapy; the FDA's Oncology Center of Excellence authorized 76 oncology devices in 2024, including two new NGS-based tumor profiling assays with companion diagnostic claims. Genetics Testing posts the highest CAGR, at approximately 14.0%, driven by advancing technologies and rising cancer and prenatal screening awareness.
Chemiluminescence Immunoassay Testing is the largest technology, valued for precision and ability to detect low-level analytes. DNA Sequencing posts the highest CAGR, at approximately 13.8%, driven by rising prevalence of infectious diseases and cancer.
Independent & Reference Laboratories hold the larger end-user share, at 75%; hospital and independent laboratories represent approximately 34% of CLIA-certified laboratories but perform nearly 81% of total clinical testing volume in the U.S., according to the CDC. Hospital-Based Laboratories post the higher CAGR, at approximately 13.6%, as health systems in-source complex testing; hospital outpatient visits increased approximately 31% between 2000 and 2023, according to the Peterson-KFF Health System Tracker.
North America holds the largest regional share, at 40%, backed by dense reference laboratory networks and favorable reimbursement coverage. The NIH's All of Us Research Program expanded its genomic dataset to include whole-genome sequences from more than 414,000 participants.
The U.S. is the largest country market, driven by substantial federal investment in genomic research infrastructure; 37,981 people aged 13 and older received an HIV diagnosis in 2022, according to the CDC, sustaining demand for confirmatory infectious disease testing.
Asia-Pacific posts the highest regional CAGR, at approximately 14.3%, driven by expanding laboratory infrastructure and an aging population. More than 245 million people aged 65 and older live across the WHO Western Pacific Region, projected to double by 2050.
India is the fastest-growing country market; the Genome India Project completed whole-genome sequencing of 10,000 individuals from 83 diverse populations in 2025. China is the largest regional country market; more than 280 million free cervical cancer screenings had been conducted nationwide by 2024, detecting approximately 902,000 cases, according to the National Health Commission of China.
Next-generation sequencing cost declines are a defining trend, as laboratories replace serial immunoassay workflows with multiplexed panels evaluating dozens of biomarkers from a single specimen, reducing turnaround time for complex diagnoses.
Rising global disease burden remains the biggest driver, as conventional pathology becomes insufficient to characterize tumor biology and genetic risk. Approximately 5.0 million adults in Italy were living with diabetes in 2024, according to the International Diabetes Federation, driving endocrinology and metabolic biomarker testing.
Laboratory workforce shortages are the main restraint. Anatomic pathology departments reported vacancy rates of approximately 28.5%, according to the American Society for Clinical Pathology's 2024 Vacancy Survey, with hiring timelines for specialized roles frequently extending beyond six months.
Decentralized specimen collection presents a clear opportunity. The FDA authorized expanded use of self-collected specimens for certain HPV testing workflows in 2024, while the WHO's global target of 70% cervical cancer screening coverage highlights a significant underserved population.
The competitive landscape remains fragmented, with major reference laboratory networks including Laboratory Corporation of America, Quest Diagnostics, and Sonic Healthcare competing alongside specialized genomic providers given high accreditation barriers. Recent activity includes Laboratory Corporation of America's September 2025 acquisition of select oncology testing assets from BioReference Health for up to USD 225 million, and bioMerieux's January 2025 agreement to acquire SpinChip Diagnostics for approximately EUR 138 million, adding a rapid point-of-care immunoassay platform.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Test Type
- 1.4.2. Market Size Breakdown, by Technology
- 1.4.3. Market Size Breakdown, by End User
- 1.4.4. Market Size Breakdown, by Region
- 1.4.5. Market Size Breakdown, by Country
- 1.5. Market Data Reporting Unit
- 1.5.1. Revenue
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Industry Background
- 5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
- 5.3. Sociopolitical Impact
- 5.4. Porter's Five Forces Analysis
- 5.4.1. Bargaining Power of Buyers
- 5.4.2. Bargaining Power of Suppliers
- 5.4.3. Threat of New Entrants
- 5.4.4. Intensity of Rivalry
- 5.4.5. Threat of Substitutes
- 5.5. Lifecycle Analysis
- 5.6. Innovation and Technology Trends
- 5.7. Economic and Regulatory Impact
- 5.8. Market Entry Strategies
Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Market Share of Key Players (2025)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East and Africa
- 6.3. Competitive Benchmarking of Key Players
- 6.4. Product Benchmarking of Key Players
- 6.5. Recent Strategic Developments by Key Players
- 6.6. Company Leadership Matrix
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Test Type (2021-2032)
- 7.3. Market Revenue, by Technology (2021-2032)
- 7.4. Market Revenue, by End User (2021-2032)
- 7.5. Market Revenue, by Region (2021-2032)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Test Type (2021-2032)
- 8.3. Market Revenue, by Technology (2021-2032)
- 8.4. Market Revenue, by End User (2021-2032)
- 8.5. Market Revenue, by Country (2021-2032)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Test Type (2021-2032)
- 9.3. Market Revenue, by Technology (2021-2032)
- 9.4. Market Revenue, by End User (2021-2032)
- 9.5. Market Revenue, by Country (2021-2032)
Chapter 10. Asia-Pacific Market
- 10.1. Overview
- 10.2. Market Revenue, by Test Type (2021-2032)
- 10.3. Market Revenue, by Technology (2021-2032)
- 10.4. Market Revenue, by End User (2021-2032)
- 10.5. Market Revenue, by Country (2021-2032)
Chapter 11. Latin America Market
- 11.1. Overview
- 11.2. Market Revenue, by Test Type (2021-2032)
- 11.3. Market Revenue, by Technology (2021-2032)
- 11.4. Market Revenue, by End User (2021-2032)
- 11.5. Market Revenue, by Country (2021-2032)
Chapter 12. Middle East and Africa Market
- 12.1. Overview
- 12.2. Market Revenue, by Test Type (2021-2032)
- 12.3. Market Revenue, by Technology (2021-2032)
- 12.4. Market Revenue, by End User (2021-2032)
- 12.5. Market Revenue, by Country (2021-2032)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Economic Indicators
- 13.3. Demographics and Population Insights
- 13.4. Growth Drivers
- 13.5. Challenges and Barriers
- 13.6. Competitive Strategies
- 13.7. Emerging Players
- 13.8. Market Size and Forecast
- 13.8.1. Market Revenue, by Test Type (2021-2032)
- 13.8.2. Market Revenue, by Technology (2021-2032)
- 13.8.3. Market Revenue, by End User (2021-2032)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Economic Indicators
- 14.3. Demographics and Population Insights
- 14.4. Growth Drivers
- 14.5. Challenges and Barriers
- 14.6. Competitive Strategies
- 14.7. Emerging Players
- 14.8. Market Size and Forecast
- 14.8.1. Market Revenue, by Test Type (2021-2032)
- 14.8.2. Market Revenue, by Technology (2021-2032)
- 14.8.3. Market Revenue, by End User (2021-2032)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Economic Indicators
- 15.3. Demographics and Population Insights
- 15.4. Growth Drivers
- 15.5. Challenges and Barriers
- 15.6. Competitive Strategies
- 15.7. Emerging Players
- 15.8. Market Size and Forecast
- 15.8.1. Market Revenue, by Test Type (2021-2032)
- 15.8.2. Market Revenue, by Technology (2021-2032)
- 15.8.3. Market Revenue, by End User (2021-2032)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Economic Indicators
- 16.3. Demographics and Population Insights
- 16.4. Growth Drivers
- 16.5. Challenges and Barriers
- 16.6. Competitive Strategies
- 16.7. Emerging Players
- 16.8. Market Size and Forecast
- 16.8.1. Market Revenue, by Test Type (2021-2032)
- 16.8.2. Market Revenue, by Technology (2021-2032)
- 16.8.3. Market Revenue, by End User (2021-2032)
Chapter 17. France Market
- 17.1. Overview
- 17.2. Economic Indicators
- 17.3. Demographics and Population Insights
- 17.4. Growth Drivers
- 17.5. Challenges and Barriers
- 17.6. Competitive Strategies
- 17.7. Emerging Players
- 17.8. Market Size and Forecast
- 17.8.1. Market Revenue, by Test Type (2021-2032)
- 17.8.2. Market Revenue, by Technology (2021-2032)
- 17.8.3. Market Revenue, by End User (2021-2032)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Economic Indicators
- 18.3. Demographics and Population Insights
- 18.4. Growth Drivers
- 18.5. Challenges and Barriers
- 18.6. Competitive Strategies
- 18.7. Emerging Players
- 18.8. Market Size and Forecast
- 18.8.1. Market Revenue, by Test Type (2021-2032)
- 18.8.2. Market Revenue, by Technology (2021-2032)
- 18.8.3. Market Revenue, by End User (2021-2032)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Economic Indicators
- 19.3. Demographics and Population Insights
- 19.4. Growth Drivers
- 19.5. Challenges and Barriers
- 19.6. Competitive Strategies
- 19.7. Emerging Players
- 19.8. Market Size and Forecast
- 19.8.1. Market Revenue, by Test Type (2021-2032)
- 19.8.2. Market Revenue, by Technology (2021-2032)
- 19.8.3. Market Revenue, by End User (2021-2032)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Economic Indicators
- 20.3. Demographics and Population Insights
- 20.4. Growth Drivers
- 20.5. Challenges and Barriers
- 20.6. Competitive Strategies
- 20.7. Emerging Players
- 20.8. Market Size and Forecast
- 20.8.1. Market Revenue, by Test Type (2021-2032)
- 20.8.2. Market Revenue, by Technology (2021-2032)
- 20.8.3. Market Revenue, by End User (2021-2032)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Economic Indicators
- 21.3. Demographics and Population Insights
- 21.4. Growth Drivers
- 21.5. Challenges and Barriers
- 21.6. Competitive Strategies
- 21.7. Emerging Players
- 21.8. Market Size and Forecast
- 21.8.1. Market Revenue, by Test Type (2021-2032)
- 21.8.2. Market Revenue, by Technology (2021-2032)
- 21.8.3. Market Revenue, by End User (2021-2032)
Chapter 22. Japan Market
- 22.1. Overview
- 22.2. Economic Indicators
- 22.3. Demographics and Population Insights
- 22.4. Growth Drivers
- 22.5. Challenges and Barriers
- 22.6. Competitive Strategies
- 22.7. Emerging Players
- 22.8. Market Size and Forecast
- 22.8.1. Market Revenue, by Test Type (2021-2032)
- 22.8.2. Market Revenue, by Technology (2021-2032)
- 22.8.3. Market Revenue, by End User (2021-2032)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Economic Indicators
- 23.3. Demographics and Population Insights
- 23.4. Growth Drivers
- 23.5. Challenges and Barriers
- 23.6. Competitive Strategies
- 23.7. Emerging Players
- 23.8. Market Size and Forecast
- 23.8.1. Market Revenue, by Test Type (2021-2032)
- 23.8.2. Market Revenue, by Technology (2021-2032)
- 23.8.3. Market Revenue, by End User (2021-2032)
Chapter 24. Australia Market
- 24.1. Overview
- 24.2. Economic Indicators
- 24.3. Demographics and Population Insights
- 24.4. Growth Drivers
- 24.5. Challenges and Barriers
- 24.6. Competitive Strategies
- 24.7. Emerging Players
- 24.8. Market Size and Forecast
- 24.8.1. Market Revenue, by Test Type (2021-2032)
- 24.8.2. Market Revenue, by Technology (2021-2032)
- 24.8.3. Market Revenue, by End User (2021-2032)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Economic Indicators
- 25.3. Demographics and Population Insights
- 25.4. Growth Drivers
- 25.5. Challenges and Barriers
- 25.6. Competitive Strategies
- 25.7. Emerging Players
- 25.8. Market Size and Forecast
- 25.8.1. Market Revenue, by Test Type (2021-2032)
- 25.8.2. Market Revenue, by Technology (2021-2032)
- 25.8.3. Market Revenue, by End User (2021-2032)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Economic Indicators
- 26.3. Demographics and Population Insights
- 26.4. Growth Drivers
- 26.5. Challenges and Barriers
- 26.6. Competitive Strategies
- 26.7. Emerging Players
- 26.8. Market Size and Forecast
- 26.8.1. Market Revenue, by Test Type (2021-2032)
- 26.8.2. Market Revenue, by Technology (2021-2032)
- 26.8.3. Market Revenue, by End User (2021-2032)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Economic Indicators
- 27.3. Demographics and Population Insights
- 27.4. Growth Drivers
- 27.5. Challenges and Barriers
- 27.6. Competitive Strategies
- 27.7. Emerging Players
- 27.8. Market Size and Forecast
- 27.8.1. Market Revenue, by Test Type (2021-2032)
- 27.8.2. Market Revenue, by Technology (2021-2032)
- 27.8.3. Market Revenue, by End User (2021-2032)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Economic Indicators
- 28.3. Demographics and Population Insights
- 28.4. Growth Drivers
- 28.5. Challenges and Barriers
- 28.6. Competitive Strategies
- 28.7. Emerging Players
- 28.8. Market Size and Forecast
- 28.8.1. Market Revenue, by Test Type (2021-2032)
- 28.8.2. Market Revenue, by Technology (2021-2032)
- 28.8.3. Market Revenue, by End User (2021-2032)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Economic Indicators
- 29.3. Demographics and Population Insights
- 29.4. Growth Drivers
- 29.5. Challenges and Barriers
- 29.6. Competitive Strategies
- 29.7. Emerging Players
- 29.8. Market Size and Forecast
- 29.8.1. Market Revenue, by Test Type (2021-2032)
- 29.8.2. Market Revenue, by Technology (2021-2032)
- 29.8.3. Market Revenue, by End User (2021-2032)
Chapter 30. Company Profiles
Chapter 31. Appendix
- 31.1. Sources and References
- 31.2. Related Reports
